Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine

Nav

General Info

Geography

Finland (FIN)

Time period covered

01/2001 - 12/2004

Data type

Scientific literature

Keywords

Diarrhea, Diarrheal diseases, Rotavirus

Citation

Authors

Vesikari T, Karvonen A, Ferrante SA, Kuter BJ, Ciarlet M

Journal

Pediatr Infect Dis J

Volume

Issue

Pages

957-63

Publication year

2010

Suggested citation

Vesikari T, Karvonen A, Ferrante SA, Kuter BJ, Ciarlet M. Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine. Pediatr Infect Dis J. 2010; 29(10): 957-63.

DOI

10.1097/INF.0b013e3181e28e6e

PMID

20442684

GHDx Entry last modified on: Mar 12, 2024

Header sites

Search form

Main menu

Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine

Nav